These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10554093)

  • 1. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
    Kamm W; Raddatz P; Gante J; Kissel T
    Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.
    Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.
    Bak A; Gudmundsson OS; Friis GJ; Siahaan TJ; Borchardt RT
    Pharm Res; 1999 Jan; 16(1):24-9. PubMed ID: 9950274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of peptidomimetic thrombin inhibitors with a 3-amidino-phenylalanine structure: permeability and efflux mechanism in monolayers of a human intestinal cell line (Caco-2).
    Kamm W; Hauptmann J; Behrens I; Stürzebecher J; Dullweber F; Gohlke H; Stubbs M; Klebe G; Kissel T
    Pharm Res; 2001 Aug; 18(8):1110-8. PubMed ID: 11587481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2).
    Annaert P; Kinget R; Naesens L; de Clercq E; Augustijns P
    Pharm Res; 1997 Apr; 14(4):492-6. PubMed ID: 9144737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics.
    Camenisch GP; Wang W; Wang B; Borchardt RT
    Pharm Res; 1998 Aug; 15(8):1174-81. PubMed ID: 9706046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.
    Prueksaritanont T; DeLuna P; Gorham LM; Ma B; Cohn D; Pang J; Xu X; Leung K; Lin JH
    Drug Metab Dispos; 1998 Jun; 26(6):520-7. PubMed ID: 9616186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug.
    Zhou L; Lee K; Thakker DR; Boykin DW; Tidwell RR; Hall JE
    Pharm Res; 2002 Nov; 19(11):1689-95. PubMed ID: 12458675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
    Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
    J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
    Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
    Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of transport mechanism of prodrugs and parent drugs formed by intracellular metabolism in Caco-2 cells with modified carboxylesterase activity: temocapril as a model case.
    Ohura K; Nozawa T; Murakami K; Imai T
    J Pharm Sci; 2011 Sep; 100(9):3985-94. PubMed ID: 21618543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
    Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
    Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.
    Watkins ME; Wring S; Randolph R; Park S; Powell K; Lutz L; Nowakowski M; Ramabhadran R; Domanico PL
    J Pharm Sci; 2017 Mar; 106(3):906-919. PubMed ID: 27986599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrug and analog approaches to improving the intestinal absorption of a cyclic peptide, GPIIb/IIIa receptor antagonist.
    Saitoh H; Aungst BJ
    Pharm Res; 1997 Aug; 14(8):1026-9. PubMed ID: 9279884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport kinetics of iron chelators and their chelates in Caco-2 cells.
    Huang XP; Spino M; Thiessen JJ
    Pharm Res; 2006 Feb; 23(2):280-90. PubMed ID: 16388408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.